Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The medication has not been studied or approved for fertility enhancement, and its FDA label does not include fertility improvement as an indication or documented effect
When the molecule is made, tested, and dosed under protocol, the dominant risks are GI tolerability and the known incretin-class effects physicians are learning to manage
The underlying mechanisms of GLP-1 receptor agonism make these medications particularly suited to addressing both conditions simultaneously
Use the same needle entry point on the vial septum each time to minimize additional puncture sites
US$ 29.59
US$ 23.65
US$ 25.55
US$ 25.14
US$ 22.08
